Itch as the major mediator of the effect of tofacitinib on health-related quality of life in PSA: a mediation analysis Tekijä Taylor, P, Bushmakin, AG, Cappelleri, JC, Young, P, Germino, R, Merola, JF, Yosipovitch, G

Itch as major mediator of effect of tofacitinib on health-related quality of life in psoriatic arthritis: a mediation analysis Tekijä Taylor, PC, Bushmakin, AG, Cappelleri, JC, Young, P, Germino, R, Merola, JF, Yosipovitch, G

Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies Tekijä Taylor, P, Bushmakin, AG, Cappelleri, JC, Young, P, Germino, R, Merola, JF, Yosipovitch, G

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo Tekijä Gladman, DD, Coates, LC, Wu, J, Fallon, L, Bacci, ED, Cappelleri, JC, Bushmakin, AG, Helliwell, PS

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in Phase 3 studies of tofacitinib Tekijä Coates, L, Bushmakin, AG, FitzGerald, O, Gladman, DD, Fallon, L, Cappelleri, JC, Hsu, MA, Helliwell, PS

Pain and inflammation as mediators of tofacitinib treatment effect on fatigue in patients with ankylosing spondylitis: a mediation analysis Tekijä Kristensen, LE, Navarro-Compán, V, Magrey, M, Bushmakin, AG, Cappelleri, JC, Yndestad, A, Dina, O, Taylor, PC

Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and ski... Tekijä Taylor, PC, De Vlam, K, Bushmakin, AG, Fallon, L, Merola, JF, Cappelleri, JC, Hsu, MA, Mease, PJ

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib Tekijä de Vlam, K, Ogdie, A, Bushmakin, AG, Cappelleri, JC, Fleischmann, R, Taylor, PC, Azevedo, V, Fallon, L, Woolcott, J, Mease, PJ

Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis Tekijä de Vlam, K, Mease, PJ, Bushmakin, AG, Fleischmann, R, Ogdie, A, Azevedo, VF, Merola, JF, Woolcott, J, Cappelleri, JC, Fallon, L, Taylor, PC